Skip to content
OpenCapital
Get started

Bioventus BVS International Segment — Total Net Sales

Other segment segments

U.S. Segment
$116.45M+5.4%

Similar metrics at other companies

Signet Jewelers logo
SIGInternational segment — Total sales
$87.5M+9.2%
AngioDynamics logo
ANGOInternational — Net Sales
$11.15M+4.5%
iRadimed logo
IRMDInternational — Total Revenue
$3.95M+11.1%
MSA
MSAInternational segment — Net Sales
$138.39M+8.0%
Globus Medical logo
GMEDInternational — Net Sales
$154.97M+35.6%
Solventum logo
SOLVInternational — Total Net Sales
$914.25M-1.0%

Other financials

Income statement

See full
Revenue$132.1M+6.6%
Gross profit$90.8M+9.3%
Operating income$8.4M+72.8%
Net income$3.1M+218%
EPS (diluted)$0.04+200%

Balance sheet

See full
Cash & equivalents$35.8M+57.2%
Total debt$288.4M-21.2%
Total equity$188.9M+27.5%
Total assets$650.5M-5.9%

Cash flow

See full
Operating cash flow$8.9M+146%
CapEx$574.0K-30.5%
Free cash flow$8.4M+141%

Valuation

See full
Market cap$659.19M+51.7%
Enterprise value$911.76M+17.2%
P/E23.1×—
P/S1.1×+0.4×

Profitability

See full
Gross margin68.7%+1.2pp
Operating margin10%—
Net margin4.9%+3.2pp
FCF margin17.5%+13.2pp

Returns & leverage

See full
Return on equity16.9%+10.9pp
Debt / equity1.5×-0.9×
Current ratio1.7×+0.3×

Where this comes from

Reported directly by Bioventus in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Bioventus’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bioventus's international segment — total net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bioventus's international segment — total net sales?
Bioventus (BVS) reported international segment — total net sales of $15.64M in Q1 2026.
How has Bioventus's international segment — total net sales changed year-over-year?
Bioventus's international segment — total net sales increased by 17.1% year-over-year, from $13.36M to $15.64M.
What is the long-term trend for Bioventus's international segment — total net sales?
Over 3 years (2022 to 2025), Bioventus's international segment — total net sales has grown at a 5.1% compound annual growth rate (CAGR), from $56.87M to $65.99M.
What does international segment — total net sales mean?
Represents the total revenue generated from the sale of medical technology products and services within international markets. This metric reflects the company's global market penetration and the demand for its orthopedic and surgical solutions outside of its primary domestic region.